Enveric Historical Income Statement

ENVB Stock

USD 0.44 0.04 8.33%

Historical analysis of Enveric Biosciences income statement accounts such as Total Revenue of 0.0 or Other Operating Expenses of 15.6 K can show how well Enveric Biosciences performed in making a profits. Evaluating Enveric Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Enveric Biosciences's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Enveric Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Enveric Biosciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enveric Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.

About Enveric Income Statement Analysis

Enveric Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Enveric Biosciences shareholders. The income statement also shows Enveric investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Enveric Biosciences Income Statement Chart

At present, Enveric Biosciences' Income Tax Expense is projected to decrease significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to 3,157, whereas Depreciation And Amortization is forecasted to decline to 326.78.

Other Operating Expenses Cost Of Revenue Total Operating Expenses Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Enveric Biosciences. It is also known as Enveric Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Enveric Biosciences income statement and represents the costs associated with goods and services Enveric Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Enveric Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Enveric Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enveric Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.At present, Enveric Biosciences' Income Tax Expense is projected to decrease significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to 3,157, whereas Depreciation And Amortization is forecasted to decline to 326.78.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	25.9M	20.0M	16.4K	15.6K
Cost Of Revenue	681.6K	435.2K	408.0K	387.6K

Total Operating Expenses Cost Of Revenue

Enveric Biosciences income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Net Income	Income Tax Expense	Income Before Tax	Total Other Income Expense Net	Research Development	Selling General Administrative	Selling And Marketing Expenses	Tax Provision	Net Interest Income	Net Income From Continuing Ops	Reconciled Depreciation	Interest Income
Depreciation And Amortization		0.81	0.77	0.78	0.95	-0.13	-0.25	-0.12	0.92	0.64	-0.25	0.17	-0.18	-0.18	-0.14	0.53	0.94	0.45	-0.4	0.09	0.26	0.27
Interest Expense	0.81		0.89	0.73	0.83	0.08	-0.04	0.07	0.87	0.42	-0.03	0.2	0.02	-0.43	-0.33	0.32	0.73	0.55	-0.52	0.32	0.21	0.28
Total Revenue	0.77	0.89		0.76	0.69	0.22	0.08	0.2	0.81	0.28	0.11	0.26	0.16	-0.51	-0.48	0.23	0.72	0.52	-0.69	0.51	0.35	0.41
Gross Profit	0.78	0.73	0.76		0.73	0.21	0.14	0.25	0.93	0.28	0.12	0.28	0.17	-0.47	-0.41	0.21	0.75	0.4	-0.67	0.41	0.59	0.34
Other Operating Expenses	0.95	0.83	0.69	0.73		-0.3	-0.43	-0.3	0.88	0.79	-0.38	-0.05	-0.34	-0.01	0.04	0.67	0.82	0.28	-0.29	-0.01	0.18	0.31
Operating Income	-0.13	0.08	0.22	0.21	-0.3		0.95	0.96	0.09	-0.79	0.97	0.66	0.99	-0.79	-0.71	-0.78	0.02	0.47	-0.49	0.81	0.41	-0.2
Ebit	-0.25	-0.04	0.08	0.14	-0.43	0.95		0.99	-0.01	-0.89	0.92	0.6	0.93	-0.81	-0.78	-0.82	-0.1	0.33	-0.46	0.66	0.46	-0.25
Ebitda	-0.12	0.07	0.2	0.25	-0.3	0.96	0.99		0.12	-0.82	0.91	0.64	0.93	-0.86	-0.82	-0.76	0.03	0.41	-0.53	0.69	0.5	-0.22
Cost Of Revenue	0.92	0.87	0.81	0.93	0.88	0.09	-0.01	0.12		0.44	0.0	0.2	0.04	-0.38	-0.33	0.34	0.85	0.43	-0.57	0.3	0.45	0.28
Total Operating Expenses	0.64	0.42	0.28	0.28	0.79	-0.79	-0.89	-0.82	0.44		-0.81	-0.42	-0.8	0.55	0.56	0.9	0.49	-0.09	0.17	-0.45	-0.21	0.33
Net Income	-0.25	-0.03	0.11	0.12	-0.38	0.97	0.92	0.91	0.0	-0.81		0.49	0.98	-0.66	-0.63	-0.8	-0.12	0.27	-0.4	0.81	0.38	-0.22
Income Tax Expense	0.17	0.2	0.26	0.28	-0.05	0.66	0.6	0.64	0.2	-0.42	0.49		0.63	-0.7	-0.41	-0.47	0.37	0.88	-0.45	0.49	0.25	-0.08
Income Before Tax	-0.18	0.02	0.16	0.17	-0.34	0.99	0.93	0.93	0.04	-0.8	0.98	0.63		-0.72	-0.65	-0.8	-0.03	0.42	-0.44	0.81	0.38	-0.21
Total Other Income Expense Net	-0.18	-0.43	-0.51	-0.47	-0.01	-0.79	-0.81	-0.86	-0.38	0.55	-0.66	-0.7	-0.72		0.83	0.43	-0.24	-0.64	0.66	-0.62	-0.49	0.04
Research Development	-0.14	-0.33	-0.48	-0.41	0.04	-0.71	-0.78	-0.82	-0.33	0.56	-0.63	-0.41	-0.65	0.83		0.47	-0.22	-0.31	0.54	-0.49	-0.41	0.19
Selling General Administrative	0.53	0.32	0.23	0.21	0.67	-0.78	-0.82	-0.76	0.34	0.9	-0.8	-0.47	-0.8	0.43	0.47		0.31	-0.18	0.2	-0.51	-0.16	0.29
Selling And Marketing Expenses	0.94	0.73	0.72	0.75	0.82	0.02	-0.1	0.03	0.85	0.49	-0.12	0.37	-0.03	-0.24	-0.22	0.31		0.56	-0.45	0.19	0.25	0.19
Tax Provision	0.45	0.55	0.52	0.4	0.28	0.47	0.33	0.41	0.43	-0.09	0.27	0.88	0.42	-0.64	-0.31	-0.18	0.56		-0.4	0.41	0.06	-0.02
Net Interest Income	-0.4	-0.52	-0.69	-0.67	-0.29	-0.49	-0.46	-0.53	-0.57	0.17	-0.4	-0.45	-0.44	0.66	0.54	0.2	-0.45	-0.4		-0.74	-0.84	-0.6
Net Income From Continuing Ops	0.09	0.32	0.51	0.41	-0.01	0.81	0.66	0.69	0.3	-0.45	0.81	0.49	0.81	-0.62	-0.49	-0.51	0.19	0.41	-0.74		0.56	0.31
Reconciled Depreciation	0.26	0.21	0.35	0.59	0.18	0.41	0.46	0.5	0.45	-0.21	0.38	0.25	0.38	-0.49	-0.41	-0.16	0.25	0.06	-0.84	0.56		0.51
Interest Income	0.27	0.28	0.41	0.34	0.31	-0.2	-0.25	-0.22	0.28	0.33	-0.22	-0.08	-0.21	0.04	0.19	0.29	0.19	-0.02	-0.6	0.31	0.51

Click cells to compare fundamentals

Enveric Biosciences Account Relationship Matchups

Enveric Biosciences income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	2.3M	120.9K	681.6K	435.2K	343.98	326.78
Interest Expense	691.1K	445.3K	10.3K	5.2K	3.7K	3.5K
Gross Profit	8.2M	(120.9K)	(681.6K)	(435.2K)	(408.0K)	(387.6K)
Other Operating Expenses	46.2M	5.6M	25.9M	20.0M	16.4K	15.6K
Operating Income	(6.3M)	(5.6M)	(64.6M)	(27.4M)	(16.4K)	(17.3K)
Ebit	(6.3M)	(6.5M)	(27.1M)	(20.0M)	(16.4K)	(17.3K)
Ebitda	(4.1M)	(6.4M)	(26.4M)	(19.5M)	(16.1K)	(16.9K)
Cost Of Revenue	31.8M	120.9K	681.6K	435.2K	408.0K	387.6K
Total Operating Expenses	14.5M	5.6M	25.9M	20.0M	16.4K	15.6K
Net Income	(5.6M)	(6.4M)	(49.0M)	(18.5M)	(17.3K)	(18.2K)
Income Tax Expense	388.7K	(477.7K)	(7.5M)	(1.5M)	28.91	30.36
Income Before Tax	(5.2M)	(6.9M)	(56.4M)	(20.0M)	(17.3K)	(18.1K)
Total Other Income Expense Net	1.1M	(1.2M)	8.2M	7.5M	(814.38)	(773.66)
Selling General Administrative	2.3K	5.4M	20.5M	11.6M	8.9K	8.4K
Tax Provision	388.7K	415.9K	(7.5M)	(1.5M)	(1.5M)	(1.4M)
Net Interest Income	(691.1K)	(445.3K)	(10.3K)	(5.2K)	3.0K	3.2K
Net Income From Continuing Ops	(5.6M)	(6.9M)	(49.0M)	(18.5M)	(22.5M)	(23.7M)
Reconciled Depreciation	2.3M	120.9K	681.6K	435.2K	414.0K	393.3K
Net Income Applicable To Common Shares	(1.9M)	(2.4M)	(6.9M)	(49.0M)	(44.1M)	(41.9M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

AVAV	AeroVironment
ELVN	Enliven Therapeutics
NFLX	Netflix

When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock:

How To Invest In Enveric

Details

Is Enveric Stock a good investment?

Details

What is Enveric Biosciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. If investors know Enveric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enveric Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.98)

Revenue Per Share

37.678

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.81)

Return On Equity

(2.06)

The market value of Enveric Biosciences is measured differently than its book value, which is the value of Enveric that is recorded on the company's balance sheet. Investors also form their own opinion of Enveric Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Enveric Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enveric Biosciences' market value can be influenced by many factors that don't directly affect Enveric Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enveric Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enveric Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enveric Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enveric Historical Income Statement

About Enveric Income Statement Analysis

Enveric Biosciences Income Statement Chart

Other Operating Expenses

Cost Of Revenue

Total Operating Expenses

Enveric Biosciences income statement Correlations

Enveric Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enveric Biosciences income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 0.99	Operating Income
Ebitda	+ 0.99	Ebit
Income Before Tax	+ 0.98	Net Income
Net Income	+ 0.97	Operating Income
Ebitda	+ 0.96	Operating Income
Other Operating Expenses	+ 0.95	Depreciation And Amortization

Total Operating Expenses	- 0.89	Ebit
Total Other Income Expense Net	- 0.86	Ebitda
Reconciled Depreciation	- 0.84	Net Interest Income
Research Development	- 0.82	Ebitda
Total Operating Expenses	- 0.82	Ebitda
Selling General Administrative	- 0.82	Ebit